<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US">
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
    <title>soapnote.org = calculators + decision tools + SOAP samples</title>
    <link rel="stylesheet" href="../../lib/style.css" type="text/css" media="all"/>
    <script type="text/javascript" src="../../lib/jquery.min.js"></script>
    <script type="text/javascript" src="../../lib/jquery-ui.min.js"></script>
    <script>
        function copyToClipboard(element) {
                $("body").append("<textarea id='temp' style='position:absolute;opacity:0;'></textarea>");
                $("#temp").val($(element).val()).select();
                document.execCommand("copy");
                $("#temp").remove();
                alert('Result has been copied!');
        }
    </script>
    </head>
    <body>
        <div id="container" class="embed_client">
                <h1 class="entry-title">ckd-dm</h1>
                <div class="form-view-content ">
                        <form id="form_1" method="get" autocomplete="off">
                                <input type="hidden" class="input_permalink" name="input_permalink" value=""/>Chronic Kidney Disease in Diabetes Mellitus - Decision Tool<span class="exclude"><br>Summary:  This decision tool assists with management of patients with diabetic nephropathy (diabetes mellitus-related chronic kidney disease, stages III, IV, and V).  It is <strong>not</strong> intended to manage CKD patients on dialysis.<br><i>Note:  Detection of kidney disease should prompt a workup to determine the cause.  A recommended initial evaluation includes Complete Metabolic Panel, Urinalysis, Urine Albumin to Creatinine Ratio (UACR), Uric Acid, Phosphate, Complete Blood Count, ANA screen, Rheumatoid Factor, C3, C4, Hepatitis B sAg, Hepatitis C Ab, dilated retinal exam, and renal Ultrasound; if patient is over 40 years & UACR is positive then Serum and Urine Protein Electrophoreses, as well.</i></span><br>Lab and objective findings:<br>1. Estimated GFR --> <select name="Q1"><option value="GFR 30 - 59: CKD Stage III">GFR 30 - 59: CKD Stage III</option><option value="GFR 15 - 29: CKD Stage IV">GFR 15 - 29: CKD Stage IV</option><option value="GFR 0 - 14: CKD Stage V">GFR 0 - 14: CKD Stage V</option></select>  <span class="memo exclude">note:  Chronic Kidney Disease (CKD) is estimated Glomerular Filtration Rate (eGFR) < 60 ml/min or kidney damage for â‰¥ 3 months (e.g. urine sediment, abnormal imaging, or albuminuria (Urine Albumin to Creatinine Ratio (UACR) < 30mg/g = nl, 30-300 = micro, >300 = macro))</span><br>2. Gender --> <select name="Q2"><option value="male">male</option><option value="female">female</option></select><br>3. Bicarbonate Level --> <select name="Q3"><option value="22 mmol/L and above (goal)">22 mmol/L and above (goal)</option><option value="less than 22 mmol/L">less than 22 mmol/L</option></select><br>4. <span name="conditional_560fa7903d2fb" class="hidden">Goal hemoglobin level for men is 13.5 mg/dL and above.</span><span name="conditional_560fa7903d560" class="hidden">Goal hemoglobin level for women is 12 mg/dL and above.</span>  Hemoglobin Level --> <select name="Q4"><option value="at or above goal">at or above goal</option><option value="low">low</option></select><br>5. Blood Pressure --> <select name="Q5"><option value="below 130/80 (goal)">below 130/80 (goal)</option><option value="130/80 and above">130/80 and above</option></select><br>6. Calcium Level --> <select name="Q6"><option value="above 10.2 mg/dL (very high)">above 10.2 mg/dL (very high)</option><option value="9.6 to 10.2 mg/dL (high)">9.6 to 10.2 mg/dL (high)</option><option value="8.4 to 9.5 mg/dL (goal)">8.4 to 9.5 mg/dL (goal)</option><option value="less than 8.4 mg/dL (low)">less than 8.4 mg/dL (low)</option></select><br>7. <span name="conditional_560fa7903d6f7" class="hidden">Goal Phosphate levels for CKD Stage III is 2.7 - 4.6 mg/dL.</span><span name="conditional_560fa7903d870" class="hidden">Goal Phosphate levels for CKD Stage IV is 2.7 - 4.6 mg/dL.</span><span name="conditional_560fa7903d9d8" class="hidden">Goal Phosphate levels for CKD Stage V is 3.5 - 5.4 mg/dL.</span>Phosphate Level --> <select name="Q7"><option value="at goal">at goal</option><option value="high">high</option></select><br>8. <span name="conditional_560fa7903db43" class="hidden">iPTH levels for CKD Stage III:  Low is less than 35 pg/mL.  Goal is 35 - 70 pg/mL.  High is more than 70 pg/mL.</span><span name="conditional_560fa7903dcaa" class="hidden">iPTH levels for CKD Stage IV:  Low is less than 70 pg/mL.  Goal is 70 - 110 pg/mL.  High is more than 110 pg/mL.</span><span name="conditional_560fa7903de0e" class="hidden">iPTH levels for CKD Stage V:  Low is less than 150 pg/mL.  Goal is 150 - 300 pg/mL.  High is more than 300 pg/mL.</span>Intact Parathyroid Hormone (iPTH) Level --> <select name="Q8"><option value="low">low</option><option value="at goal">at goal</option><option value="high">high</option></select><br>9. 25(OH)D (Vitamin D) Level --> <select name="Q9"><option value="30 mg/mL and above (goal)">30 mg/mL and above (goal)</option><option value="less than 30 mg/mL">less than 30 mg/mL</option></select><br>Recommendations:<br><span name="conditional_560fa7903df7b" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903e0b3">Follow up visit in 3 months.  Referral to registered dietician.  Lab interval for stage III CKD:  Creatinine and eGFR - Each visit; UACR - Every 3 or 6 months; Hb - Every 3 months; Fe, Transferrin Sat, Ferritin - Every 3 months; Ca, PO4, and iPTH - At least annually.  </textarea></span><span name="conditional_560fa7903e21d" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903e35f">Follow up visit in at least 1 to 3 months. Referral to registered dietician.  Referral to nephrologist.  Lab interval for stage IV CKD:  Creatinine and eGFR - Each visit; UACR - Each visit; Hb - Every 3 months; Fe, Transferrin Sat, Ferritin - Every 3 months; Ca, PO4, and iPTH - Every 3 months.  </textarea></span><span name="conditional_560fa7903e4c6" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903e5f0">Follow up visit in at least 1 to 3 months.  Referral to registered dietician.  Referral to nephrologist.  Lab interval for stage V CKD (not on dialysis)Creatinine and eGFR - Each visit;UACR - Each visit;Hb - Every 3 months;Fe, Transferrin Sat, Ferritin - Every 3 months;Ca, PO4, and iPTH - Every 3 months.  </textarea></span><br><span name="conditional_560fa7903e73e" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903e843">Acidosis is controlled.  Continue maintenance therapy if present, i.e.sodium bicarbonate 325-650 mg (1 to 2 tabs) TID to QID.  </textarea></span><span name="conditional_560fa7903e98c" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903ea8e">Acidosis is uncontrolled.  Sodium bicarbonate 325-650 mg (1 to 2 tabs) TID to QID.  </textarea></span><br><span name="conditional_560fa7903ebd7" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903ed10">No anemia therapy indicated.  Continue ongoing iron supplementation as appropriate.  Monitor ferritin to avoid iron overload.  </textarea></span><span name="conditional_560fa7903ee53" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903efb2">Anemia is present.  Additional evaluation for other anemia causes: B12/folate; hemoccult/FIT/colonoscopy;Baseline Labs for anemia of CKD: Ferritin; iron studies (Fe, % Sat, TIBC); CBC with differential.  If ferritin/iron studies are low --> Start oral iron therapy, i.e. Ferrous Sulfate (FeSO4) 325mg QD to TID.  Docusate 100mg BID as needed to reduce constipation. Monitor ferritin to avoid iron overload.  If Hb < 9 with symptoms unresponsive to treatment--> IV iron/blood transfusion/erythropoiesis stimulating agents</textarea></span><br><span name="conditional_560fa7903f0ff" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903f1fb">Hypertension is controlled.  Continue current therapy (ACE/ARB is first line).</textarea></span><span name="conditional_560fa7903f384" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903f48c">Hypertension is uncontrolled.  Increase ACE/ARB dosage; Add additional agent to lower blood pressure to goal < 130/80.  </textarea></span><br><span name="conditional_560fa7903f5e3" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903f725">Severe hypercalcemia with low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.</textarea></span><span name="conditional_560fa7903f86e" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903f9ad">Severe hypercalcemia with low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa7903faf0" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903fc22">Severe hypercalcemia.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa7903fd62" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7903fe96">Severe hypercalcemia with low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa7903ffe7" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904012d">Severe hypercalcemia with elevated parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  </textarea></span><span name="conditional_560fa790430bb" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79043283">Severe hypercalcemia with elevated parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  </textarea></span><span name="conditional_560fa7904341b" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa790435c4">Severe hypercalcemia with hyperphosphatemia and low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79043718" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa790438ae">Severe hypercalcemia with hyperphosphatemia and low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa790439f7" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79043b82">Severe hypercalcemia with hyperphosphatemia.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79043cd6" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79043e61">Severe hypercalcemia with hyperphosphatemia and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79043fa2" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904414d">Severe hypercalcemia with hyperphosphatemia and elevated parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa7904428b" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79044416">Severe hypercalcemia with hyperphosphatemia, elevated parathyroid hormone, and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Correct causes for hypercalcemia.  Decrease calcium by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79044558" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79044678">Hypercalcemia with low parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa790447b2" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa790448e9">Hypercalcemia with low parathyroid hormone and low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Although vitamin D is low, supplementing this vitamin could harmfully increase calcium level.  </textarea></span><span name="conditional_560fa79044a24" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79044b3e">Hypercalcemia.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa79044c87" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79044dc0">Hypercalcemia with low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH and decrease calcium by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Although vitamin D is low, supplementing this vitamin could harmfully increase calcium level.  </textarea></span><span name="conditional_560fa79044ef8" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79045039">Hypercalcemia with elevated parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  </textarea></span><span name="conditional_560fa79045171" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa790452a2">Hypercalcemia with elevated parathyroid hormone and low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Although vitamin D is low, supplementing this vitamin could harmfully increase calcium level.  </textarea></span><span name="conditional_560fa790453dd" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79045557">Hypercalcemia and hyperphosphatemia with low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium and increase iPTH by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79045690" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79045809">Hypercalcemia and hyperphosphatemia with low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium and increase iPTH by holding calcitriol, vitamin D, and avoiding calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79045947" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79045abf">Hypercalcemia and hyperphosphatemia.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79045bfb" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79045d8d">Hypercalcemia and hyperphosphatemia with low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  If necessary, cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.Although vitamin D is low, supplementing this vitamin could harmfully increase calcium level.  </textarea></span><span name="conditional_560fa79045edf" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79048e7e">Hypercalcemia and hyperphosphatemia with elevated parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa79049065" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79049230">Hypercalcemia and hyperphosphatemia with elevated parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Decrease calcium by holding calcitriol and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Cinacalcet 30-180 mg daily may be used to decrease calcium, phosphate, and PTH.  Lanthanum 1500-3750 mg/day with meals to decrease phosphate and calcium.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.Although vitamin D is low, supplementing this vitamin could harmfully increase calcium level.  </textarea></span><span name="conditional_560fa79049383" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa790494a8">Low parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa790495df" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79049700">Low parathyroid hormone and low vitain D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa79049838" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904994c">Phosphate, calcium, iPTH, and vitamin D are all at goal.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Continue current medications.  </textarea></span><span name="conditional_560fa79049a89" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79049b9b">Low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase vitamin D with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa79049cd8" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa79049e0a">Elevated parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Reduce iPTH with calcitriol 0.25-1 mcg daily or 0.5-3 mcg TIW.  </textarea></span><span name="conditional_560fa79049f57" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904a074">Elevated parathyroid hormone and low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Reduce iPTH and increase vitamin D with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904a1a4" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904a307">Hyperphosphatemia with low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa7904a47b" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904a5df">Hyperphosphatemia with low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa7904a722" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904a866">Hyperphosphatemia.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  </textarea></span><span name="conditional_560fa7904a998" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904ab07">Hyperphosphatemia with low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.Increase vitamin D with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904ac43" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904adb3">Hyperphosphatemia with elevated parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.Reduce iPTH with calcitriol 0.25-1 mcg daily or 0.5-3 mcg TIW.  </textarea></span><span name="conditional_560fa7904aefb" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904b070">Hyperphosphatemia with elevated parathyroid hormone and low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.Reduce iPTH and increase vitamin D with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904b1a5" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904b2d0">Hypocalcemia with low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH by holding calcitriol, vitamin D, and/or calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa7904b3fe" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904b52c">Hypocalcemia with low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase iPTH by holding calcitriol, vitamin D, and/or calcium-based phosphate binders.  </textarea></span><span name="conditional_560fa7904b660" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904b79a">Hypocalcemia.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase calcium by starting/increasing calcium supplementation.  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  </textarea></span><span name="conditional_560fa7904b8c7" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904ba19">Hypocalcemia with low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Increase calcium and vitamin D by starting/increasing calcium supplementation and/or vitamin D.  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Increase vitamin D with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904bb4c" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904bc67">Hypocalcemia with elevated parathyroid hormone.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Reduce iPTH and increase calcium with calcitriol 0.25-1 mcg daily or 0.5-3 mcg TIW.  </textarea></span><span name="conditional_560fa7904bda6" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904bed7">Hypocalcemia with elevated parathyroid hormone and low vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day.  Reduce iPTH, increase vitamin D, and increase calcium with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904ec3b" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904ee34">Hypocalcemia and hyperphosphatemia with low parathyroid hormone.  Further investigation is warranted.  Consider nephrology consultation.  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa7904efcf" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904f14d">Hypocalcemia and hyperphosphatemia with low parathyroid hormone and low vitamin D.  Further investigation is warranted.  Consider nephrology consultation.  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  Increase iPTH by holding calcitriol, vitamin D, and calcium-based phosphate binders.  Sevelamer (Renagel) 800-1600 mg TID may be used to decrease phosphate.  Aluminum 600-1200 mg TID between meals & HS.  Can be used for up to 30 days to decrease phosphate if it is above 7 mg/dL.  </textarea></span><span name="conditional_560fa7904f28d" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904f3d7">Hypocalcemia and hyperphosphatemia.  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  </textarea></span><span name="conditional_560fa7904f503" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904f658">Hypocalcemia and hyperphosphatemia with low Vitamin D.  Diet:  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Reduce iPTH, increase vitamin D, and increase calcium with ergocalciferol 1.25-5 mg daily.  </textarea></span><span name="conditional_560fa7904f787" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904f8d6">Hypocalcemia and hyperphosphatemia with elevated parathyroid hormone.  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Reduce iPTH and increase calcium with calcitriol 0.25-1 mcg daily or 0.5-3 mcg TIW.  </textarea></span><span name="conditional_560fa7904fa02" class="hidden"><textarea cols="60" rows="5" name="textarea_560fa7904fb72">Hypocalcemia and hyperphosphatemia with elevated parathyroid hormone and low vitamin D.  Limit dietary phosphate to 800-1000 mg/day (consult/reconsult registered dietician).  CaCO3 (Oyst-Cal or TUMS) 500-2000 mg with meals to decrease phosphate and increase calcium. Ca Acetate 1334-2868 mg with meals to decrease phosphate (when it's above 5 mg/dL) and increase calcium.  Reduce iPTH, increase vitamin D, and increase calcium with ergocalciferol 1.25-5 mg daily.  </textarea></span><br><span class="exclude"><hr></span><span class="checkbox" name="footnotes"> <label><input type="checkbox" name="footnotes" value="" /> </label></span><span class="memo exclude">display/hide footnotes</span><span name="conditional_560fa7904fcb1" class="hidden"><span class="exclude"><br>reference:  Indian Health Service Guideline (2010) <a href="http://www.ihs.gov/MedicalPrograms/Diabetes/HomeDocs/Tools/Algorithms/DM_algorithm_CKD_508c.pdf" target="_blank">Type 2 Diabetes - Chronic Kidney Disease</a>.  FP notebook page:  <a href="http://www.fpnotebook.com/renal/Rheum/RnlOstdystrphy.htm" target="_blank">Renal Osteodystrophy</a>.</span><br>posted by:  Mark Morgan, M.D.<br>post/review dates:  August 18, 2013; September 3, 2015; October 3, 2015<br>permalink: <a href="http://www.soapnote.org/kidney/ckd-dm/" target="_blank">www.soapnote.org/kidney/ckd-dm/</a><br>markup link:  <a href="http://www.soapnote.org/txt/kidney/ckd-dm.txt" target="_blank">www.soapnote.org/txt/kidney/ckd-dm.txt</a>[/html]</span><input type="button" class="soapnote_submit exclude" value="Submit"/>
<div class="soapnote_result_container exclude">
Result - Copy or Print this text:
<div class="result_buttons">
<a  onclick="copyToClipboard('.soapnote_result')" rel="nofollow" title="Copy to clipboard" href="javascript:void(0)" class="button copy-button exclude">Copy</a>
<a rel="nofollow" title="Print" href="javascript:void(0)" class="button print-button exclude">Print</a>
</div>
<textarea class="soapnote_result exclude" cols="80" rows="12" onclick="this.focus();this.select();" readonly="readonly"></textarea>
</div>
</form>
<script type="text/javascript">
if (typeof vars == 'undefined') vars = new Array();
vars[1] = {};
if (typeof conditions == 'undefined') conditions = new Array();
conditions[1] = new Array();
conditions[1].push({logic:"(Q2).is('male')", show:"conditional_560fa7903d2fb"});
conditions[1].push({logic:"(Q2).is('female')", show:"conditional_560fa7903d560"});
conditions[1].push({logic:"(Q1).is('GFR 30 - 59: CKD Stage III')", show:"conditional_560fa7903d6f7"});
conditions[1].push({logic:"(Q1).is('GFR 15 - 29: CKD Stage IV')", show:"conditional_560fa7903d870"});
conditions[1].push({logic:"(Q1).is('GFR 0 - 14: CKD Stage V')", show:"conditional_560fa7903d9d8"});
conditions[1].push({logic:"(Q1).is('GFR 30 - 59: CKD Stage III')", show:"conditional_560fa7903db43"});
conditions[1].push({logic:"(Q1).is('GFR 15 - 29: CKD Stage IV')", show:"conditional_560fa7903dcaa"});
conditions[1].push({logic:"(Q1).is('GFR 0 - 14: CKD Stage V')", show:"conditional_560fa7903de0e"});
conditions[1].push({logic:"(Q1).is('GFR 30 - 59: CKD Stage III')", show:"conditional_560fa7903df7b"});
conditions[1].push({logic:"(Q1).is('GFR 15 - 29: CKD Stage IV')", show:"conditional_560fa7903e21d"});
conditions[1].push({logic:"(Q1).is('GFR 0 - 14: CKD Stage V')", show:"conditional_560fa7903e4c6"});
conditions[1].push({logic:"(Q3).is('22 mmol/L and above (goal)')", show:"conditional_560fa7903e73e"});
conditions[1].push({logic:"(Q3).is('less than 22 mmol/L')", show:"conditional_560fa7903e98c"});
conditions[1].push({logic:"(Q4).is('at or above goal')", show:"conditional_560fa7903ebd7"});
conditions[1].push({logic:"(Q4).is('low')", show:"conditional_560fa7903ee53"});
conditions[1].push({logic:"(Q5).is('below 130/80 (goal)')", show:"conditional_560fa7903f0ff"});
conditions[1].push({logic:"(Q5).is('130/80 and above')", show:"conditional_560fa7903f384"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7903f5e3"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7903f86e"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7903faf0"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7903fd62"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7903ffe7"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa790430bb"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904341b"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79043718"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa790439f7"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79043cd6"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79043fa2"});
conditions[1].push({logic:"(Q6).is('above 10.2 mg/dL (very high)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904428b"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79044558"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa790447b2"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79044a24"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79044c87"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79044ef8"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79045171"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa790453dd"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79045690"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79045947"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79045bfb"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79045edf"});
conditions[1].push({logic:"(Q6).is('9.6 to 10.2 mg/dL (high)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79049065"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79049383"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa790495df"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79049838"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79049a89"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa79049cd8"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa79049f57"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904a1a4"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904a47b"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904a722"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904a998"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904ac43"});
conditions[1].push({logic:"(Q6).is('8.4 to 9.5 mg/dL (goal)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904aefb"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904b1a5"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904b3fe"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904b660"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904b8c7"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904bb4c"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('at goal')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904bda6"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904ec3b"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('low')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904efcf"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904f28d"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('at goal')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904f503"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('30 mg/mL and above (goal)')", show:"conditional_560fa7904f787"});
conditions[1].push({logic:"(Q6).is('less than 8.4 mg/dL (low)')&&(Q7).is('high')&&(Q8).is('high')&&(Q9).is('less than 30 mg/mL')", show:"conditional_560fa7904fa02"});
conditions[1].push({logic:"(footnotes).is('')", show:"conditional_560fa7904fcb1"});
jQuery(document).ready(function($) {
				$('#form_1').find('input[name="Q2"], select[name="Q2"], input[name="Q1"], select[name="Q1"], input[name="Q3"], select[name="Q3"], input[name="Q4"], select[name="Q4"], input[name="Q5"], select[name="Q5"], input[name="Q6"], select[name="Q6"], input[name="Q7"], select[name="Q7"], input[name="Q8"], select[name="Q8"], input[name="Q9"], select[name="Q9"], input[name="footnotes"], select[name="footnotes"]').change(function() {
					if ($(this).attr('type') == 'checkbox') {
						vars[1][$(this).attr('name')] = new Array();
						$(this).parents('.checkbox').find(':checked').each(function() {
							vars[1][$(this).attr('name')].push($(this).val());
						});
					}
					else vars[1][$(this).attr('name')] = $(this).val();
					$.each(conditions[1], function(index, condition) { 
						$.each(vars[1], function(index, value) { 
							condition.logic = condition.logic.replace(new RegExp('\\('+index+'\\)', 'g'), 'vars[1][\''+index+'\']');
						});
						
						try {
							if (eval(condition.logic) === true) $('#form_1 [name="'+condition.show+'"]').removeClass('hidden');
							else $('#form_1 [name='+condition.show+']').addClass('hidden');
							}
						catch(err) {
							$('#form_1 [name='+condition.show+']').addClass('hidden');
						}
					});
				});
				$('#form_1').find('input[name="Q2"], select[name="Q2"], input[name="Q1"], select[name="Q1"], input[name="Q3"], select[name="Q3"], input[name="Q4"], select[name="Q4"], input[name="Q5"], select[name="Q5"], input[name="Q6"], select[name="Q6"], input[name="Q7"], select[name="Q7"], input[name="Q8"], select[name="Q8"], input[name="Q9"], select[name="Q9"], input[name="footnotes"], select[name="footnotes"]').change();
			});
			</script>

<script type="text/javascript">

jQuery(document).ready(function($){
$(".print-button").click(function(){
                doPrint($(this).parents('.soapnote_result_container').find('.soapnote_result').val().replace(/\n/g,"\r\n"));
        });
});
</script>
<script type="text/javascript" src="../../lib/form.js"></script>
</div>
</div>
</body>
</html>
